New Key Statistics Module, Z-Score and F-Score
OTCPK:NONOF Key Ratios
Market Cap $ M | 556,217.19 |
Enterprise Value $ M | 554,250.66 |
P/E(ttm) | 46.28 |
PE Ratio without NRI | 46.28 |
Forward PE Ratio | 38.53 |
Price/Book | 36.55 |
Price/Sales | 16.94 |
Price/Free Cash Flow | 56.27 |
Price/Owner Earnings | 45.37 |
Payout Ratio % | 0.38 |
Revenue (TTM) $ M | 33,619.00 |
EPS (TTM) $ | 2.69 |
Beneish M-Score | -2.58 |
10-y EBITDA Growth Rate % | 11.70 |
5-y EBITDA Growth Rate % | 17.50 |
y-y EBITDA Growth Rate % | 50.90 |
EV-to-EBIT | 36.11 |
EV-to-EBITDA | 33.16 |
PEG | 2.64 |
Shares Outstanding M | 4,461.33 |
Net Margin (%) | 36.03 |
Operating Margin % | 44.16 |
Pre-tax Margin (%) | 45.07 |
Quick Ratio | 0.64 |
Current Ratio | 0.82 |
ROA % (ttm) | 30.18 |
ROE % (ttm) | 92.29 |
ROIC % (ttm) | 30.03 |
Dividend Yield % | 1.10 |
Altman Z-Score | 13.36 |
NONOF Number of Guru Trades
NONOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:NONOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:NONOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Novo Nordisk A/S Insider Transactions
No Available Data
News about OTCPK:NONOF
Total 0- 1